A PHASE-I TRIAL OF CONTINUOUS INFUSION VP16-213 (ETOPOSIDE)

被引：58

作者：

AISNER, J

VANECHO, DA

WHITACRE, M

WIERNIK, PH

机构：

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 7卷 / 2-3期

关键词：

D O I：

10.1007/BF00254539

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：157 / 160

页数：4

共 10 条

[1]

DINCALCI M, 1981, 1ST P INT S POD CANC

[2]

DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715

[3] VP16-213 AS A SINGLE AGENT IN ADVANCED TESTICULAR-TUMORS [J].

FITZHARRIS, BM ;

KAYE, SB ;

SAVERYMUTTU, S ;

NEWLANDS, ES ;

BARRETT, A ;

PECKHAM, MJ ;

MCELWAIN, TJ .

EUROPEAN JOURNAL OF CANCER, 1980, 16 (09) :1193-1197

[4]

RADICE PA, 1979, CANCER TREAT REP, V63, P1231

[5]

ROZENCWEIG M, 1977, CANCER, V40, P334, DOI 10.1002/1097-0142(197707)40:1<334::AID-CNCR2820400147>3.0.CO

[6]

2-X

[7]

SCHELL FC, 1981, P AM ASSOC CANC RES, V22, P357

[8]

VENDITTI JM, 1971, CANC CHEMOTHER REP, V2, P35

[9]

WILLIAMS SD, 1980, CANCER, V46, P2154, DOI 10.1002/1097-0142(19801115)46:10<2154::AID-CNCR2820461008>3.0.CO

[10]

2-3

← 1 →